dinolytic 5 mg-ml razt za injic
zoetis belgium sa rue laid burniat 1 1348 louvain -
dalmaprost
support pharma -
omnipaque 240 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 240 mg / 1 mljoheksol - joheksol
omnipaque 300 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 300 mg / 1 ml - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 mljoheksol - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 ml - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 mljoheksol - joheksol
omnipaque 350 mg i/ml raztopina za injiciranje
ge healthcare as - jod - raztopina za injiciranje - jod 350 mg / 1 ml - joheksol
mastiquick
genera si -
quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - okužbe, pridobljene v skupnosti - antibacterials za sistemsko uporabo, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.